Autor: |
Republican Scientific, Irina Buynevich, E.A. Grigorenko, A.A. Pleshko, D. Yu. Ruzanov, Elena Davidovskaya |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Emergency Cardiology and Cardiovascular Risks. 4:1074-1084 |
ISSN: |
2616-633X |
DOI: |
10.51922/2616-633x.2020.4.2.1074 |
Popis: |
The publication provides a brief overview of the most significant pathogenetic and pathophysiological mechanisms that will explain the phenomenon of comorbidity of chronic obstructive pulmonary disease (COPD) and cardiovascular pathology (CVD). Moreover, in this review is considered the potential impact of the recommended treatment of COPD on the risks and course of cardiovascular diseases from the perspective of evidence-based medicine. It has been shown that COPD and cardiovascular diseases share single risk factors, common pathogenetic mechanisms, unidirectional pathophysiological processes, similar clinical symptoms and effects synergistically with respect to adverse events and outcomes, which allows us to attribute this combination to category of comorbid pathology. The presented results of randomized clinical trials and meta-analyzes demonstrate that currently no COPD guidelines contain detailed clinical recommendations for assessing cardiovascular risk in this category of patients, nor are there enough guidelines for the treatment of COPD in patients with cardiovascular disease or vice versa. In terms of international experience, it is substantiated that the comorbid pathology of COPD and CVD should not be considered isolated from each other. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|